Literature DB >> 29935687

Evolving Treatment Strategies and Outcomes in Advanced Gastric Cancer with Peritoneal Metastasis.

Fadi S Dahdaleh1, Kiran K Turaga2.   

Abstract

Gastric cancer (GC) has a predilection to metastasize to the peritoneum, denoting a poor prognosis. Treatment strategies available for advanced GC have significantly evolved over time and can be categorized into systemic, regional, and surgical. Although systemic therapies have been the mainstay for the treatment of advanced GC, their ability in achieving long-term survival in patients with peritoneal involvement is modest at best. This article describes advances in combined modality treatment of peritoneal metastases, specifically with an emphasis on peritoneal-directed therapies.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Advanced gastric cancer; Chemotherapy; Cytoreductive surgery; HIPEC; Peritoneal metastasis; Regional intraperitoneal chemotherapy; Targeted therapy

Mesh：

Year:  2018        PMID： 29935687     DOI： 10.1016/j.soc.2018.02.006

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN： 1055-3207            Impact factor:   3.495


  10 in total

Review 1.  Is PIPAC a Treatment Option in Upper and Lower Gastrointestinal Cancer with Peritoneal Metastasis?

Authors:  Safak Guel-Klein; Miguel Enrique Alberto Vilchez; Wim Ceelen; Beate Rau; Andreas Brandl
Journal:  Visc Med       Date:  2022-03-21

2.  Investigating the mechanisms of peritoneal metastasis in gastric adenocarcinoma using a novel ex vivo peritoneal explant model.

Authors:  Marco Magalhaes; Carol J Swallow; Deanna Ng; Aiman Ali; Kiera Lee; Denise Eymael; Kento Abe; Shelly Luu; Karineh Kazazian; Yi Qing Lu; Savtaj Brar; James Conner
Journal:  Sci Rep       Date:  2022-07-07       Impact factor: 4.996

3.  Comparison of Docetaxel + Oxaliplatin + S-1 vs Oxalipatin + S-1 as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Propensity Score Matched Analysis.

Authors:  Xin Zhang; Hejing Huang; Ziran Wei; Zhenxin Zhu; Dejun Yang; Hongbing Fu; Jiapeng Xu; Zunqi Hu; Yu Zhang; Qing You; Xin Huang; Ronglin Yan; Weimin Wang; Qingping Cai
Journal:  Cancer Manag Res       Date:  2020-07-30       Impact factor: 3.989

4.  LPPR4 promotes peritoneal metastasis via Sp1/integrin α/FAK signaling in gastric cancer.

Authors:  Dan Zang; Chuang Zhang; Ce Li; Yibo Fan; Zhi Li; Kezuo Hou; Xiaofang Che; Yunpeng Liu; Xiujuan Qu
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

5.  Management Of Synchronous Krukenberg Tumors From Gastric Cancer: a Single-center Experience.

Authors:  Dingding Yan; Yian Du; Gaiguo Dai; Ling Huang; Qi Xu; Pengfei Yu
Journal:  J Cancer       Date:  2018-10-20       Impact factor: 4.207

6.  Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C/D) in patients with gastric cancer and peritoneal metastasis: a phase II study.

Authors:  Florian Struller; Philipp Horvath; Wiebke Solass; Frank-Jürgen Weinreich; Dirk Strumberg; Marios K Kokkalis; Imma Fischer; Christoph Meisner; Alfred Königsrainer; Marc A Reymond
Journal:  Ther Adv Med Oncol       Date:  2019-05-13       Impact factor: 8.168

Review 7.  Overcoming Drug Resistance by Taking Advantage of Physical Principles: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC).

Authors:  Giorgi Nadiradze; Philipp Horvath; Yaroslav Sautkin; Rami Archid; Frank-Jürgen Weinreich; Alfred Königsrainer; Marc A Reymond
Journal:  Cancers (Basel)       Date:  2019-12-20       Impact factor: 6.639

8.  Reduced expression of exosomal miR‑29s in peritoneal fluid is a useful predictor of peritoneal recurrence after curative resection of gastric cancer with serosal involvement.

Authors:  Hideyuki Ohzawa; Akira Saito; Yuko Kumagai; Yuki Kimura; Hironori Yamaguchi; Yoshinori Hosoya; Alan Kawarai Lefor; Naohiro Sata; Joji Kitayama
Journal:  Oncol Rep       Date:  2020-02-17       Impact factor: 3.906

9.  Pharmacologic Targeting of MMP2/9 Decreases Peritoneal Metastasis Formation of Colorectal Cancer in a Human Ex Vivo Peritoneum Culture Model.

Authors:  Jana Koch; Dina Mönch; Annika Maaß; Alina Mangold; Miodrag Gužvić; Thomas Mürdter; Tobias Leibold; Marc-H Dahlke; Philipp Renner
Journal:  Cancers (Basel)       Date:  2022-08-02       Impact factor: 6.575

10.  Neoadjuvant Intraperitoneal and Systemic Chemotherapy Versus Neoadjuvant Systemic Chemotherapy With Docetaxel, Oxaliplatin, and S-1 for Gastric Cancer With Peritoneal Metastasis: A Propensity Score Matched Analysis.

Authors:  Xin Zhang; Hejing Huang; Dejun Yang; Peng Wang; Xin Huang; Zunqi Hu; Yu Zhang; Ronglin Yan; Zhenxin Zhu; Qingping Cai
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.